Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are yervoy's side effects more manageable than other cancer treatments?What's the best time to exercise on lipitor?Can tigecycline's liver enzyme effects be managed in susceptible patients?Are there any risks in combining lipitor and joint supplements?How does one manage lurbinectedin's adverse reactions?
See the DrugPatentWatch profile for Opill
What is Opill, and what's its status in the US market? Opill is an emergency contraceptive pill developed by Alembic Pharmaceuticals, which acquired the rights to the US market for the product. The pill contains norgestrel, a synthetic progestin that can prevent pregnancy if taken within five days (120 hours) of unprotected sex [1]. Can Opill be purchased over-the-counter (OTC)? Currently, Opill is not available for purchase without a prescription (OTC) in the US. However, its manufacturer, Alembic Pharmaceuticals, has applied for an OTC switch through the FDA, arguing that the risks of norgestrel are low enough to allow for non-prescription sales [2]. The FDA is yet to make a decision on this application. Comparison to other emergency contraceptives Prescription-only emergency contraceptives like Plan B One-Step and Ella are already available in the US. In November 2022, a generic equivalent of Plan B was approved for OTC sales [3]. If Opill's OTC switch is approved, it could expand access to emergency contraceptives, but it's unclear if it will also impact the market share of existing OTC and prescription-only options. Timeline of Opill availability The FDA review process for Opill's OTC switch is ongoing, which may delay its availability without a prescription. If approved, the product would likely become available OTC nationwide. If you're looking for emergency contraceptive options, it's essential to check the most recent information on approved products and their availability in your area. Cited sources [1] DrugPatentWatch.com: Opill [2] FDA: Prescription Drug User Fee Act (PDUFA) VII Performance Goal – 2023 – Over-the-Counter (OTC) Monoclass Rule [3] FDA: Natazia (drospirenone and ethinyl estradiol, estradiol, or estetrol and estradiol) – FDA Approval History Note: This information may change as new regulatory decisions are made or products become available in the market.